1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
    Journal Article

    Omuro, A.; Brandes, A. A.; Carpentier, A. F.; Idbaih, A.; Reardon, D. A.; Cloughesy, T.; Sumrall, A.; Baehring, J.; van den Bent, M.; Bähr, O.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Overall survival with maintenance olaparib at a 7-year follow-up in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: The SOLO1/GOG 3004 trial
    Journal Article

    DiSilvestro, P.; Banerjee, S.; Colombo, N.; Scambia, G.; Kim, B. G.; Oaknin, A.; Friedlander, M.; Lisyanskaya, A.; Floquet, A.; Leary, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • High-dose cytarabine and autologous stem-cell transplantation in mantle cell lymphoma: Long-term follow-up of the randomized Mantle Cell Lymphoma Younger trial of the European Mantle Cell Lymphoma Network
    Journal Article

    Hermine, O.; Jiang, L.; Walewski, J.; Bosly, A.; Thieblemont, C.; Szymczyk, M.; Pott, C.; Salles, G.; Feugier, P.; Hübel, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: A subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial
    Journal Article

    Tomita, Y.; Kobayashi, K.; Kimura, G.; Oya, M.; Uemura, H.; Nishiyama, H.; Galsky, M. D.; Nasroulah, F.; Collette, S.; Broughton, E.; more...
    Japanese Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Pexidartinib provides modest pain relief in patients with tenosynovial giant cell tumor: Results from ENLIVEN
    Journal Article

    Healey, J. H.; Tap, W. D.; Gelhorn, H. L.; Ye, X.; Speck, R. M.; Palmerini, E.; Stacchiotti, S.; Desai, J.; Wagner, A. J.; Alcindor, T.; more...
    Clinical Orthopaedics and Related Research (2023)

    Fulltext@MSK | Save
  • Impact of a virtual professional development coaching program on the professional fulfillment and well-being of women surgery residents: A randomized controlled trial
    Journal Article

    Palamara, K.; McKinley, S. K.; Chu, J. T.; Merrill, A. L.; Yu, L.; Parangi, S.; Makowski, M. S.; Park, Y. S.; Donelan, K.; Stein, S. L.
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma
    Journal Article

    D'Souza, A.; Brazauskas, R.; Stadtmauer, E. A.; Pasquini, M. C.; Hari, P.; Bashey, A.; Callander, N.; Devine, S.; Efebera, Y.; Ganguly, S.; more...
    American Journal of Hematology (2023)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma
    Journal Article

    Usmani, S. Z.; Nahi, H.; Legiec, W.; Grosicki, S.; Vorobyev, V.; Spicka, I.; Hungria, V.; Korenkova, S.; Bahlis, N. J.; Flogegard, M.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma
    Journal Article

    O'Malley, D. M.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Gynecologic Oncology (2022)

    Fulltext@MSK | Save